134 related articles for article (PubMed ID: 31912951)
1. Eczematous reaction to ixekizumab successfully treated with dupilumab.
Napolitano M; Gallo L; Patruno C; Fabbrocini G; Megna M
Dermatol Ther; 2020 Mar; 33(2):e13218. PubMed ID: 31912951
[No Abstract] [Full Text] [Related]
2. Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab.
Bai H; Murase EM; Ashbaugh AG; Botto NB; Murase JE
J Am Acad Dermatol; 2022 Sep; 87(3):692-695. PubMed ID: 35367296
[No Abstract] [Full Text] [Related]
3. Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab.
Megna M; Genco L; Noto M; Patruno C; Fabbrocini G; Napolitano M
Dermatol Ther; 2022 Nov; 35(11):e15839. PubMed ID: 36111349
[No Abstract] [Full Text] [Related]
4. The role of dupilumab in the management of idiopathic chronic eczematous eruption of aging.
Shahriari N; Strober B; Shahriari M
J Am Acad Dermatol; 2020 Nov; 83(5):1533-1535. PubMed ID: 32679275
[No Abstract] [Full Text] [Related]
5. Dupilumab for severe generalized eczematous eruption complicating common variable immunodeficiency.
Votquenne N; Dupire G; Michel O; Ben Said B
Eur J Dermatol; 2021 Feb; 31(1):93-94. PubMed ID: 33586652
[No Abstract] [Full Text] [Related]
6. Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.
Hendricks AJ; Yosipovitch G; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):19-28. PubMed ID: 31693426
[No Abstract] [Full Text] [Related]
7. Machine learning analysis of pretreatment skin biopsies predicts nonresponse to dupilumab in patients with eczematous dermatitis.
Murphy MJ; Hwang E; Singh K; Lee T; Cohen JM; Damsky W
Br J Dermatol; 2023 Dec; 190(1):132-134. PubMed ID: 37818837
[No Abstract] [Full Text] [Related]
8. Paradoxical eczematous reaction to ixekizumab.
Munera-Campos M; Ballesca F; Richarz N; Ferrandiz C; Carrascosa JM
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):e40-e42. PubMed ID: 29953678
[No Abstract] [Full Text] [Related]
9. A possible role for dupilumab (Dupixent) in the management of idiopathic chronic eczematous eruption of aging.
Brummer GC; Wang LT; Sontheimer RD
Dermatol Online J; 2018 Feb; 24(2):. PubMed ID: 29630150
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy-induced eczema treated with dupilumab.
D'Erme AM; Fidanzi C; Mori N; Musettini G; Cupini S; Barbara C; Allegrini G; Bagnoni G; Janowska A
J Eur Acad Dermatol Venereol; 2024 May; 38(5):e447-e449. PubMed ID: 38084780
[No Abstract] [Full Text] [Related]
11. Strategies for Successful Management of Severe Atopic Dermatitis.
Brar KK; Nicol NH; Boguniewicz M
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):1-16. PubMed ID: 30598172
[TBL] [Abstract][Full Text] [Related]
12. Dupilumab treatment of nummular dermatitis: A retrospective cohort study.
Choi S; Zhu GA; Lewis MA; Honari G; Chiou AS; Ko J; Chen JK
J Am Acad Dermatol; 2020 May; 82(5):1252-1255. PubMed ID: 31923445
[No Abstract] [Full Text] [Related]
13. Promising results for treatment of severe chronic hand eczema with dupilumab.
Brans R
Br J Dermatol; 2023 Sep; 189(4):360-361. PubMed ID: 37337439
[No Abstract] [Full Text] [Related]
14. Dupilumab for hand eczema.
Zirwas MJ
J Am Acad Dermatol; 2018 Jul; 79(1):167-169. PubMed ID: 29535032
[No Abstract] [Full Text] [Related]
15. Treatment of chronic hand eczema with dupilumab-A retrospective follow-up study.
Olesen CM; Yüksel YT; Zachariae C; Lund TT; Agner T; Petersen TS; Thyssen JP
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e557-e559. PubMed ID: 36463422
[No Abstract] [Full Text] [Related]
16. Angioedema: A potential complication of dupilumab in atopic dermatitis.
Fritz AL; Lacy FA; Morrell DS
Pediatr Dermatol; 2021 Jan; 38(1):237-238. PubMed ID: 33099796
[TBL] [Abstract][Full Text] [Related]
17. Successful use of dupilumab to treat eczema in a child with X-linked agammaglobulinemia.
Atwal S; Ong PY
Ann Allergy Asthma Immunol; 2022 Sep; 129(3):384-386. PubMed ID: 35772636
[No Abstract] [Full Text] [Related]
18. A review of dupilumab in the treatment of atopic diseases.
Thibodeaux Q; Smith MP; Ly K; Beck K; Liao W; Bhutani T
Hum Vaccin Immunother; 2019; 15(9):2129-2139. PubMed ID: 30785362
[TBL] [Abstract][Full Text] [Related]
19. A case of Atopic dermatitis and Hidradenitis Suppurativa successfully treated with Dupilumab.
Gambardella A; Calabrese G; Di Brizzi EV; Alfano R; Argenziano G
J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):e284-e286. PubMed ID: 32034813
[No Abstract] [Full Text] [Related]
20. Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition.
Napolitano M; Megna M; Fabbrocini G; Nisticò SP; Balato N; Dastoli S; Patruno C
Br J Dermatol; 2019 Sep; 181(3):604-606. PubMed ID: 30768788
[No Abstract] [Full Text] [Related]
[Next] [New Search]
